These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19721857)

  • 1. Significance of inflammatory markers in diabetic patients with stable coronary artery disease.
    Lee HJ; Her SH; Im YS; Won KY; Yoo SH; Kim DB; Shin DI; Kim PJ; Seung KB; Kim JH; Kim KY
    Korean J Intern Med; 2009 Sep; 24(3):212-9. PubMed ID: 19721857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus.
    Lu L; Pu LJ; Xu XW; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Lu AK; Ding FH; Shen J; Chen QJ; Lou S; Fang DH; Shen WF
    Clin Biochem; 2007 Jul; 40(11):810-6. PubMed ID: 17499233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin A1C in non-diabetic patients: an independent predictor of coronary artery disease and its severity.
    Ashraf H; Boroumand MA; Amirzadegan A; Talesh SA; Davoodi G
    Diabetes Res Clin Pract; 2013 Dec; 102(3):225-32. PubMed ID: 24176244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma interleukin-27 levels in patients with coronary artery disease.
    Miura K; Saita E; Suzuki-Sugihara N; Miyata K; Ikemura N; Ohmori R; Ikegami Y; Kishimoto Y; Kondo K; Momiyama Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8260. PubMed ID: 29068992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical role of combined serum C1q and hsCRP in predicting coronary artery disease.
    Jia Y; Wen W; Yang Y; Huang M; Ning Y; Jiao X; Liu S; Qin Y; Zhang M
    Clin Biochem; 2021 Jul; 93():50-58. PubMed ID: 33861985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
    Habib SS
    J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of plasma adiponectin & certain inflammatory markers in angiographically proven coronary artery disease patients with & without diabetes--a study from India.
    Kumpatla S; Karuppiah K; Immaneni S; Muthukumaran P; Krishnan J; Narayanamoorthy SK; Viswanathan V
    Indian J Med Res; 2014 Jun; 139(6):841-50. PubMed ID: 25109718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between glycated albumin or hemoglobin A1c and the presence of coronary artery disease.
    Norimatsu K; Miura S; Suematsu Y; Shiga Y; Miyase Y; Nakamura A; Yamada M; Matsunaga A; Saku K
    J Cardiol; 2015 Jun; 65(6):487-93. PubMed ID: 25107604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum high-sensitivity C-reactive protein and lipoprotein(a) levels: a comparison between diabetic and non-diabetic patients with coronary artery disease.
    Shahid HS; Kurdi MI; Zohair AA
    Med J Malaysia; 2011 Jun; 66(2):113-6. PubMed ID: 22106689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.
    Su G; Mi S; Tao H; Li Z; Yang H; Zheng H; Zhou Y; Ma C
    Cardiovasc Diabetol; 2011 Feb; 10():19. PubMed ID: 21349201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography.
    Arbel Y; Zlotnik M; Halkin A; Havakuk O; Berliner S; Herz I; Rabinovich I; Keren G; Bazan S; Finkelstein A; Banai S
    Clin Res Cardiol; 2014 Mar; 103(3):223-7. PubMed ID: 24271460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of leukocytes and its subsets counts with the severity of stable coronary artery disease in patients with diabetic mellitus.
    Hong LF; Li XL; Luo SH; Guo YL; Liu J; Zhu CG; Qing P; Xu RX; Wu NQ; Jiang LX; Li JJ
    PLoS One; 2014; 9(3):e90663. PubMed ID: 24599246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum myeloid-related protein 8/14 level is associated with atherosclerosis in type 2 diabetic patients.
    Peng WH; Jian WX; Li HL; Hou L; Wei YD; Li WM; Xu YW
    Cardiovasc Diabetol; 2011 May; 10():41. PubMed ID: 21592353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease.
    Taniguchi H; Momiyama Y; Ohmori R; Yonemura A; Yamashita T; Tamai S; Nakamura H; Ohsuzu F
    Atherosclerosis; 2005 Jan; 178(1):173-7. PubMed ID: 15585215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylated hemoglobin A1c predicts coronary artery disease in non-diabetic patients.
    Kayali Y; Ozder A
    J Clin Lab Anal; 2021 Feb; 35(2):e23612. PubMed ID: 33034919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein.
    Leu HB; Lin CP; Lin WT; Wu TC; Chen JW
    Chest; 2004 Oct; 126(4):1032-9. PubMed ID: 15486359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes.
    Matsubara J; Sugiyama S; Akiyama E; Iwashita S; Kurokawa H; Ohba K; Maeda H; Fujisue K; Yamamoto E; Kaikita K; Hokimoto S; Jinnouchi H; Ogawa H
    Circ J; 2013; 77(5):1337-44. PubMed ID: 23386232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of novel cytokines in inflammation: Defining peripheral artery disease among patients with coronary artery disease.
    Ozkaramanli Gur D; Guzel S; Akyuz A; Alpsoy S; Guler N
    Vasc Med; 2018 Oct; 23(5):428-436. PubMed ID: 29638194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes.
    Lu L; Pu LJ; Zhang Q; Wang LJ; Kang S; Zhang RY; Chen QJ; Wang JG; De Caterina R; Shen WF
    Atherosclerosis; 2009 Oct; 206(2):540-5. PubMed ID: 19368923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients.
    Pu LJ; Lu L; Shen WF; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Ding FH; Chen QJ; Shen J; Fang DH; Lou S
    Circ J; 2007 Jul; 71(7):1067-73. PubMed ID: 17587712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.